Image of Jennifer J. Furin

Jennifer J. Furin, M.D., Ph.D.

Jennifer Furin, MD, PhD, is an infectious diseases clinician and a medical anthropologist who focuses on global health. She received her PhD in Medical Anthropology from the University of California at Los Angeles in 1995 and her MD from Harvard Medical School in 1999. She completed her residency in internal medicine at Brigham and Women’s Hospital in 2002 and her fellowship in infectious diseases at University Hospitals Case Medical Center (Cleveland) in 2004. Dr. Furin is engaged in clinical and program work and operational research to support the treatment of multidrug-resistant tuberculosis and HIV. She has been fighting drug-resistant TB since 1995 when she began working in Lima, Peru with Partners In Health. She has significant global experience and has done work in Haiti, Peru, Russia, Lesotho, South Africa, Georgia, Bangladesh, Swaziland, and Tajikistan. She is also a member of the Tuberculosis Transformation Science Committee of the AIDS Clinical Trials Group. She serves as a high-level consultant for a number of National TB Programs, WHO, USAID, and Médecins Sans Frontières

Affiliations:

Dr. Furin is also an adjunct assistant professor in the Department of Anthropology at Case Western Reserve University

Dr. Furin is the director of Clinical Capacity Building for the Sentinel Project on Pediatric Drug-Resistant Tuberculosis

Dr. Furin is participating in teaching and research in the Department's Sentinel Project on Pediatric Drug-Resistant Tuberculosis.

Erratum for Alsultan et al., "Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary Tuberculosis".
Authors: Authors: Alsultan A, Furin JJ, Du Bois J, van Brakel E, Chheng P, Venter A, Thiel B, Debanne SA, Boom WH, Diacon AH, Johnson JL, Peloquin CA.
Antimicrob Agents Chemother
View full abstract on Pubmed
Population implications of the use of bedaquiline in people with extensively drug-resistant tuberculosis: are fears of resistance justified?
Authors: Authors: Kunkel A, Furin J, Cohen T.
Lancet Infect Dis
View full abstract on Pubmed
World Health Organization recommendations for multidrug-resistant tuberculosis: should different standards be applied?
Authors: Authors: Cox V, Furin J.
Int J Tuberc Lung Dis
View full abstract on Pubmed
Cross-sectional interview study of fertility, pregnancy, and urogenital schistosomiasis in coastal Kenya: Documented treatment in childhood is associated with reduced odds of subfertility among adult women.
Authors: Authors: Miller-Fellows SC, Howard L, Kramer R, Hildebrand V, Furin J, Mutuku FM, Mukoko D, Ivy JA, King CH.
PLoS Negl Trop Dis
View full abstract on Pubmed
Recommending prolonged bedaquiline use for the treatment of highly resistant strains of tuberculosis.
Authors: Authors: Furin J, Lessem E, Cox V.
Eur Respir J
View full abstract on Pubmed
The devil we know: is the use of injectable agents for the treatment of MDR-TB justified?
Authors: Authors: Reuter A, Tisile P, von Delft D, Cox H, Cox V, Ditiu L, Garcia-Prats A, Koenig S, Lessem E, Nathavitharana R, Seddon JA, Stillo J, von Delft A, Furin J.
Int J Tuberc Lung Dis
View full abstract on Pubmed
Bedaquiline or delamanid for rifampin-resistant tuberculosis?
Authors: Authors: Lessem E, Cox V, Furin J.
Lancet Respir Med
View full abstract on Pubmed
Missed opportunities for earlier diagnosis of rifampicin-resistant tuberculosis despite access to Xpert® MTB/RIF.
Authors: Authors: Mohr E, Daniels J, Muller O, Furin J, Chabalala B, Steele SJ, Cox V, Dolby T, Ferlazzo G, Shroufi A, Duran LT, Cox H.
Int J Tuberc Lung Dis
View full abstract on Pubmed
To Test or Not to Test? Ending the Age-Old Debate for Drug-Resistant Tuberculosis.
Authors: Authors: Furin J, Cox H.
Clin Infect Dis
View full abstract on Pubmed
Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary Tuberculosis.
Authors: Authors: Alsultan A, Furin JJ, Du Bois J, van Brakel E, Chheng P, Venter A, Thiel B, Debanne SA, Boom WH, Diacon AH, Johnson JL, Peloquin CA.
Antimicrob Agents Chemother
View full abstract on Pubmed